Breyanzi® support in 2L+ LBCL
Cell Therapy 360® resources are designed to support eligible patients and caregivers through the Bristol Myers Squibb CAR T-cell therapy journey, from enrollment through the initial post-infusion monitoring period
Patient support navigators
Logistical support
Financial support
Additional eligibility requirements apply. Patients may enroll in support programs offered through Cell Therapy 360 after a certified CAR T-cell therapy treatment center determines that Breyanzi is the right treatment for them.
Request a Breyanzi representative
If you have any additional questions about Breyanzi, please use the information provided below to contact a representative.
Call us at 1-800-321-1335.
2L, second-line; CAR, chimeric antigen receptor; LBCL, large B-cell lymphoma.